Skip to main content
Fig. 1 | BMC Public Health

Fig. 1

From: Acceptability, feasibility, and likelihood of stakeholders implementing the novel BPaL regimen to treat extensively drug-resistant tuberculosis patients

Fig. 1

Conceptual framework of factors influencing implementation of BPaL in an existing health care system [11]. *Specified along assessment aspects: Baseline assessment and monitoring of treatment efficacy; Treatment safety monitoring; Patient friendliness; Patient support; Programmatic aspects; Human resources; PSCM. BPaL: bedaquilline & pretomanid & linezolid, Fq: fluoroquinolone, ITR: Individualized Treatment Regimen, PSCM: Procurement and supply chain management, TB: tuberculosis

Back to article page

BMC Public Health

ISSN: 1471-2458

Contact us